Genetic variants, pathophysiological pathways, and oral anticoagulation in patients with hypertrophic cardiomyopathy and atrial fibrillation

Genetic variants, pathophysiological pathways, and oral anticoagulation in patients with hypertrophic cardiomyopathy and atrial fibrillation

Atrial fibrillation (AF) is commonly prevalent in patients with hypertrophic cardiomyopathy (HCM). However, whether the prevalence and incidence of AF are different between genotype-positive vs. genotype-negative patients with HCM remains controversial. Recent evidence has indicated that AF is often...

Full description

Bibliographic Details
Main Authors: Shengnan Wang, He Chen, Chunju Liu, Mengxian Wu, Wanlei Sun, Shenjian Liu, Yan Zheng, Wenfeng He
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
atrial fibrillation
hypertrophic cardiomyopathy
genotype
mechanism
anticoagulation
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1023394/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2023.1023394/full

Similar Items